Rayno Biopharmaceuticals Portfolio YTD Performance and New Highs: PCYC,SGEN,REGN
Biotech Stocks Hit New Highs Unfazed By Shutdown Biopharmaceutical stocks continued their blazing Q3 run today buoyed by assumptions that demand for pharmaceuticals will increase with 55 million new potential patients from Obamacare and that healthcare stocks are less affected by a weaker...
Biopharma Stocks Take Another Leg Up: ALXN, CBST, PCYC, REGN
Biotech Stocks Will Not Wait for Congress-Huge Rally Across the Board Analysts and Media are Piling On-Momentum Rules IBB up 1.75% XBI up 1.81% Rayno Biopharmaceuticals stocks are in a new leg up with large cap winners: Alexion (ALXN $115) up 2% Cubist (CBST $67.62) up 2.95% Pharmacyclics...
Biotechnology IPO Market Continues Run with Foundation Medicine (FMI)
Foundation Medicine (FMI) Soars on IPO-Up 75% Foundation Medicine (FMI $32.30), based in Cambridge MA, went public today at $18 offering 5,888,888 M shares and promptly went up 79% on volume over 4.5M shares as of early trading. See IPO Desktop for more information on the hot IPO market....
Fidelity Select Biotechnology Fund (FBIOX) Outperforms Biotech ETFs YTD
Life Science Sector at or Near YTD and All Time Highs Fidelity Fund (FBIOX) Outperform ETFs Over the past 3 years we reviewed how ETFs complement a biotechnology investment strategy and compared three of the largest and most liquid : FBT, IBB and XBI (see the articles below and our...
Politics Curb Further Market Gains-Short Term Caution
No matter what your political persuasion you should know that your dysfunctional government may weaken the economy and damage your portfolio. Jim McTague in his Sep 23 Barron's column, The GOP's Threat to Investors, provides the scenario whereby he says..." Ben Bernanke never underestimates the...